Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 1, 1999

View Archived Issues

Medigene Licenses Drug To Complement Work In HPV

Xenova Gets OK To Start U.S. Trial Of Cancer Drug

Other News To Note

Peptide's Study Of Product For Hay Fever Falls Short

Germans Discover Gene With Implications In Reproduction

European Commission Tries To Get Handle On GMO Issue

French Start-Up EntoMed Uses Insects In Platform Technology

Nexia Completes Financing To Further Develop BioSteel

Germans, Chinese Report On Methods To Research DNA

Biota Follows Up Flu Drug With Effort In Common Cold

Cambridge Antibody Brings Another Product Into Clinic

Celltech Plans Further Studies Of Anti-TNF Drug In Arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...